BG63046B1 - Пиролидинилметилиндолова сол - Google Patents

Пиролидинилметилиндолова сол Download PDF

Info

Publication number
BG63046B1
BG63046B1 BG102053A BG10205397A BG63046B1 BG 63046 B1 BG63046 B1 BG 63046B1 BG 102053 A BG102053 A BG 102053A BG 10205397 A BG10205397 A BG 10205397A BG 63046 B1 BG63046 B1 BG 63046B1
Authority
BG
Bulgaria
Prior art keywords
salt
fumarate salt
compound
fumarate
free base
Prior art date
Application number
BG102053A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102053A (en
Inventor
Martin Wythes
Original Assignee
Pfizer Research And Development Company, N.V./S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research And Development Company, N.V./S.A. filed Critical Pfizer Research And Development Company, N.V./S.A.
Publication of BG102053A publication Critical patent/BG102053A/xx
Publication of BG63046B1 publication Critical patent/BG63046B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG102053A 1995-05-20 1997-11-18 Пиролидинилметилиндолова сол BG63046B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent
PCT/EP1996/001560 WO1996036632A1 (en) 1995-05-20 1996-04-10 Pyrrolidinyl methyl indole salt

Publications (2)

Publication Number Publication Date
BG102053A BG102053A (en) 1998-06-30
BG63046B1 true BG63046B1 (bg) 2001-02-28

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102053A BG63046B1 (bg) 1995-05-20 1997-11-18 Пиролидинилметилиндолова сол

Country Status (42)

Country Link
US (1) US5994387A (de)
EP (1) EP0827503B1 (de)
JP (1) JP3233940B2 (de)
KR (1) KR100295255B1 (de)
CN (1) CN1063175C (de)
AP (1) AP738A (de)
AR (1) AR003949A1 (de)
AT (1) ATE194986T1 (de)
AU (1) AU701154B2 (de)
BG (1) BG63046B1 (de)
BR (1) BR9610858A (de)
CA (1) CA2219631C (de)
CO (1) CO5040221A1 (de)
CZ (1) CZ287939B6 (de)
DE (1) DE69609504T2 (de)
DK (1) DK0827503T3 (de)
DZ (1) DZ2034A1 (de)
ES (1) ES2148753T3 (de)
GB (1) GB9510223D0 (de)
GR (1) GR3034290T3 (de)
HK (1) HK1017884A1 (de)
HR (1) HRP960223B1 (de)
HU (1) HU217657B (de)
IL (1) IL118239A (de)
IS (1) IS1908B (de)
LV (1) LV11992B (de)
MA (1) MA23876A1 (de)
MX (1) MX9708966A (de)
MY (1) MY132066A (de)
NO (1) NO312068B1 (de)
NZ (1) NZ306448A (de)
OA (1) OA10747A (de)
PL (1) PL183142B1 (de)
PT (1) PT827503E (de)
RU (1) RU2161618C2 (de)
SK (1) SK281782B6 (de)
TN (1) TNSN96074A1 (de)
TR (1) TR199701397T1 (de)
UA (1) UA44320C2 (de)
WO (1) WO1996036632A1 (de)
YU (1) YU29496A (de)
ZA (1) ZA963938B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
EP2875020B1 (de) * 2012-07-19 2017-09-06 Boehringer Ingelheim International GmbH Verfahren zur herstellung von einem fumarsäuresalz von 9- [4- (3-chlor-2-fluor-phenylamino)-7-methoxy-chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-on

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (de) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
CO5040221A1 (es) 2001-05-29
ES2148753T3 (es) 2000-10-16
IL118239A (en) 2000-10-31
ATE194986T1 (de) 2000-08-15
UA44320C2 (uk) 2002-02-15
DZ2034A1 (fr) 2002-07-21
CA2219631A1 (en) 1996-11-21
SK154197A3 (en) 1999-01-11
LV11992A (lv) 1998-03-20
NZ306448A (en) 1998-10-28
CA2219631C (en) 2001-01-23
BR9610858A (pt) 1999-07-13
LV11992B (en) 1998-06-20
JPH10506639A (ja) 1998-06-30
GR3034290T3 (en) 2000-12-29
OA10747A (en) 2002-12-11
TR199701397T1 (xx) 1998-03-21
SK281782B6 (sk) 2001-07-10
CN1185152A (zh) 1998-06-17
KR19990014934A (ko) 1999-02-25
IL118239A0 (en) 1996-09-12
AU5500596A (en) 1996-11-29
MX9708966A (es) 1998-03-31
JP3233940B2 (ja) 2001-12-04
GB9510223D0 (en) 1995-07-19
HK1017884A1 (en) 1999-12-03
EP0827503B1 (de) 2000-07-26
AP9600801A0 (en) 1996-04-30
IS1908B (is) 2003-12-31
HRP960223A2 (en) 1997-10-31
KR100295255B1 (ko) 2001-08-07
AU701154B2 (en) 1999-01-21
IS4605A (is) 1997-10-30
HUP9801761A3 (en) 1999-06-28
NO975210D0 (no) 1997-11-13
CZ287939B6 (cs) 2001-03-14
CZ364897A3 (cs) 1998-11-11
MY132066A (en) 2007-09-28
NO975210L (no) 1997-11-13
HU217657B (hu) 2000-03-28
DK0827503T3 (da) 2000-11-20
PL183142B1 (pl) 2002-05-31
HRP960223B1 (en) 2000-12-31
PL323143A1 (en) 1998-03-16
RU2161618C2 (ru) 2001-01-10
AP738A (en) 1999-03-23
AR003949A1 (es) 1998-09-30
TNSN96074A1 (fr) 2005-03-15
PT827503E (pt) 2000-11-30
HUP9801761A2 (hu) 1999-05-28
BG102053A (en) 1998-06-30
NO312068B1 (no) 2002-03-11
CN1063175C (zh) 2001-03-14
YU29496A (sh) 1998-12-23
EP0827503A1 (de) 1998-03-11
ZA963938B (en) 1997-11-17
DE69609504D1 (de) 2000-08-31
WO1996036632A1 (en) 1996-11-21
DE69609504T2 (de) 2000-12-14
US5994387A (en) 1999-11-30
MA23876A1 (fr) 1996-12-31

Similar Documents

Publication Publication Date Title
JP2020533396A (ja) Ｇｓｋ１２７８８６３の結晶形及びその製造方法並びに医薬用途
EA011283B1 (ru) Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина
US20200283371A1 (en) Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of derivative thereof and method for preparing same
FR2883285A1 (fr) Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP2022529915A (ja) 新規な製剤
EP1641787B1 (de) Substituierte diketopiperazine und deren verwendung als oxytocynantagonisten
US5747521A (en) N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same
JP2023504912A (ja) ７ｈ－ベンゾ［７］アヌレン－２－カルボン酸誘導体の結晶形態
BG63046B1 (bg) Пиролидинилметилиндолова сол
EP2874628A2 (de) Salze und hydrate von antipsychotika
TWI285204B (en) Polymorphs of a crystalline azabicyclo[2,2.2]octan-3-amine citrate and their pharmaceutical compositions
ES2397413T3 (es) Procedimiento para la preparación de un comprimido que contiene clorhidrato de donepezilo en forma amorfa
WO2020072860A1 (en) Niraparib solid state form
JP2019089822A (ja) トピロキソスタットの新規結晶形及びその製造方法
US20230382897A1 (en) Crystalline form of lifitegrast, and pharmaceutical composition comprising the same
JP7425482B2 (ja) イソキノリンスルホンアミドの新規な形態
WO2005023803A1 (en) Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione
KR20210046028A (ko) 트레프로스티닐의 에르부민 염
WO2005023790A1 (en) (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt
WO2005023789A1 (en) Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid